News, views and contacts from the global Drugdevelopment industry
31 March 2017
Industry News

Vertex's tezacaftor shows positive outcome in two Phase III trials to treat CF
US-based biotechnology firm Vertex Pharmaceuticals has reported a positive outcome from two Phase III clinical trials of tezacaftor (VX-661) in combination with ivacaftor to treat cystic fibrosis (CF).

Millendo commences Phase II trial of ATR-101 to treat endogenous CS
US-based biopharmaceutical firm Millendo Therapeutics has commenced a Phase II clinical trial of ATR-101 for the treatment of patients with endogenous cushing’s syndrome (CS).

ARMO begins dosing in Phase III trial of AM0010 to treat pancreatic cancer
ARMO BioSciences has begun dosing patients in a Phase III clinical trial of AM0010 (PEGylated Interleukin-10) and FOLFOX combination for the treatment of advanced pancreatic cancer.

Biophytis starts enrolment for SARA-OBS trial of sarconeos in Europe
French biotechnology firm Biophytis has opened its first clinical centres in Europe and started patient enrolment for SARA-OBS clinical trial of sarconeos to treat sarcopenia.

Press Releases

Pharmatest to Host Seven Presentations at AACR in Washington, US
Pharmatest Services has announced it will attend the annual meeting of American Association for Cancer Research (AACR) in Washington, US.

Shin-Etsu Purchase Gamlen D Series for Formulation Studies
Provider of a wide range of cellulose ether excipients Shin-Etsu PFMD has purchased a Gamlen D series powder compaction analyser for a laboratory application in Wiesbaden, Germany.

Malvern March Webinars
Malvern is hosting two webinars this month: Differential scanning calorimetry (robust and powerful physical characterisation of therapeutic protein products) and Cement (composition, structure, and fineness - we are stronger together!).

Pharmatest Joins Biocom and Science Exchange Life Science Organisations in California
Pharmatest Services has announced it has joined two California-based organisations Biocom and Science Exchange.

Malvern to Host Webinar on Characterisation and Optimisation of Particle Size and Shape of Metal Powders
Efficiency of the production process of powder bed additives is reliant on packing density and flow behaviour of metal powders involved.

White Papers

Optimising Development Resources for Efficient Product Development
Development departments suffer from a shortage of resources and are often overburdened with administration...

Validated Metal Analysis
Four commonly utilized carbohydrates for ptotein stabilization are Sucrose, Trehalose, Mannitol, and...

Evaluating API and Excipient Characteristics for Tablet Formulations
Before tablet formulations are designed, any active pharmaceutical ingredients (API) and excipients should be fully understood in terms of their compressibility, compactability, and...

Improving OMNISEC Results by Switching Mobile Phases
Polylactic and polyglycolic acid are used for a number of applications including biomedical applications. Absorbable sutures, medical implant hardware, food packaging, and clothing all...

Benefits of Trehalose
Products such as monoclonal antibodies (mAb), fusion proteins, peptides, vaccines, antibody drug conjugulates (ADC) and stem cells benefit from the stabilising effects of...

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Drug Development Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.drugdevelopment-technology.com is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.